Biotech · Private company
OncoNano Medicine, Inc.
Track this companyFree. Adds OncoNano Medicine, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials41 recruiting or active
Pipeline programs6From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline6
- ONM-100Phase 2 · Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- pegsitacianinePhase 2 · Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- pegsitacianinePhase 2 · Peritoneal CarcinomatosisClinicalTrials.gov · fetched Nov 12, 2026
- Tumor resection surgeryPhase 2 · Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- CemiplimabPhase 1 · Triple Negative Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- ONM-501Phase 1 · Triple Negative Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.PHASE1 · RECRUITING · started Oct 13, 2023ClinicalTrials.gov NCT06022029 · fetched Nov 12, 2026
- A Study to Evaluate Pegsitacianine, an Intraoperative Fluorescence Imaging Agent for the Detection of Lung MalignanciesPHASE2 · COMPLETED · started Apr 13, 2022ClinicalTrials.gov NCT05048082 · fetched Nov 12, 2026
- A Study to Evaluate ONM100, an Intraoperative Fluor Imaging Agent for the Detection of Peri MetsPHASE2 · COMPLETED · started Nov 30, 2021ClinicalTrials.gov NCT04950166 · fetched Nov 12, 2026
- A Study to Evaluate ONM-100, an Intraoperative Fluorescence Imaging Agent for the Detection of CancerPHASE2 · COMPLETED · started Aug 9, 2019ClinicalTrials.gov NCT03735680 · fetched Nov 12, 2026